BiomX (PHGE-WT) has a profit margin of 22393.07%, above the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
BiomX (PHGE-WT) currently reports a profit margin of 22393.07% as of June 2026. That compares with -25605.68% in the prior-year period — up 187.5% year over year. That is above the Healthcare sector average of 10.58%. Use the charts on this page to explore BiomX's profit margin history and peer comparisons.
BiomX's profit margin increased from -25605.68% to 22393.07% — a 187.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BiomX's profit margin of 22393.07% is higher than the Healthcare sector average of 10.58%. That is roughly 211545.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but BiomX's current 22393.07% should be judged against Healthcare norms (sector average: 10.58%) and against PHGE-WT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 22393.07%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for BiomX, and consider following PHGE-WT for alerts when major investors trade the stock.